What we do and why we do it

Evaxion Biotech uses artificial intelligence (AI) to discover and develop immunotherapies and vaccines for cancer and infectious diseases. With our proprietary AI platforms, we identify key cancer or bacterial epitopes and antigens and use these to design the optimal vaccine or immunotherapy drug design. We have developed several cancer immunotherapies and infectious disease vaccines with our lead program EVX-01 cancer immunotherapy, currently in phase 2b clinical testing.

We have extensive experience in clinical and pre-clinical testing, drug delivery, immune adjuvanticity, and animal models for cancer and bacterial infections. We have recently built our own lab and animal facility in Hørsholm.

Working as a Ph.D. for Evaxion

Today, we employ ph. Ds in bioinformatics, biology, computer science, in vivo / ex vivo immunology, CMC, manufacturing, and MDs.

As a Ph.D. in Evaxion you will be directly involved in key research and development projects and influence these activities from day one. Evaxion has a flat project-based organization, and you will have a lot of independence and power over your work, research, and tasks, as well as be able to follow through with ideas.

Evaxion Biotech

Saving lives with AI-powered immunotherapies

Career Day for PhDs and Postdocs

Join the event